Enanta’s chemistry-driven approach and drug discovery capabilities are focused on small molecule drugs for the treatment of viral infections and liver diseases such as respiratory syncytial virus (RSV), hepatitis B virus (HBV), SARS-CoV-2 (COVID-19) and human metapneumovirus (hMPV). Learn more about our research.




Latest News